Skip to main content

Headlines

Will the Fallout From the SVB Failure Change the Stock Market Phase?
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Can-Fite: CHMP Issues Positive Opinion On Piclidenoson Phase III Clinical Trial
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Merck, Eisai Announce Disappointing Results From Phase 3 LEAP-003 And LEAP-017 Trials
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
AstraZeneca : Lynparza Combination Improves PFS In Phase III Ovarian Cancer Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Eisai, Biogen Present Lecanemab New Analyses In Phase 3 Trial; Detailed Analyses In Phase IIb Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Anebulo Pharma Reports Positive Results From Phase 2 Proof Of Concept Study With ANEB-001
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
GSK Announces Positive Results From Phase III Trial Of Jemperli Combination In Endometrial Cancer
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Ionis Pharma Reports Positive 66-week Results Of Eplontersen Phase 3 Study In ATTRv-PN
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Novartis : Phase III Trial Of Kisqali Combination In Early Breast Cancer Meets Primary Endpoint
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
EU hopes to steer clear of summit showdown on combustion engine phase-out
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Germany's Transport Ministry sees no need to rush combustion engine phase-out deal with EU
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Zai Lab Partner Karuna's Phase 3 Trial Of KarXT In Schizophrenia Meets Primary Endpoint
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Astellas : Phase 3 Study Of Xtandi In Metastatic Hormone-sensitive Prostate Cancer Meets Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Calliditas : Phase 3 Trial Of Nefecon In IgA Nephropathy Meets Primary Endpoint
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Merck: Phase 2/3 CCTG IND.227/KEYNOTE-483 Trial With KEYTRUDA Meets Primary Endpoint
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets